Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 May 2023 | Story Leonie Bolleurs | Photo Supplied
Spineless Cactus
Axel Tarrisse (far left), a PhD student in the Department of Sustainable Food Systems, working on the biogas and fodder potential of spineless cactus in Africa. Pictured with him are Prof Maryna de Wit, his supervisor and Associate Professor in the UFS Department of Sustainable Food Systems and Development, and Dr Herman Fouché from the Agricultural Research Council.

The spineless cactus is a unique perennial plant that is able to yield close to 40 tons of dry matter per hectare per year with a rainfall of 500 mm per annum. “This equates eight tons of biomethane or 11 000 litres of diesel-equivalent energy per hectare,” says Axel Tarrisse, a PhD student in the Department of Sustainable Food Systems and Development at the University of the Free State (UFS), who is working on the biogas and fodder potential of spineless cactus in Africa.

Tarrisse believes biogas, produced from the spineless cactus, has the potential to complement the supply of South Africa’s existing industrial energy companies to produce sustainable jet fuel and diesel and a variety of other products with the gas-to-liquid process they use.

Developing biogas

He says with rainfall, key nutrients, carbon dioxide, and solar energy it is possible to produce biomass from cactus.

“First, we harvest the cactus and macerate it prior to going into an anaerobic digester where it is heated to 38°C, the same as a cow’s body temperature. Inside the digester, naturally occurring bacteria, similar to those found in their stomachs, break down the cactus, resulting in the production of biogas. This biogas is composed of both methane and carbon dioxide,” he explains.

According to him, biogas generated through this process can be used in a number of ways. This includes running generators to produce electricity or burning it to generate heat. It will also serve as a feedstock to replace coal and natural gas used by companies such as PetroSA and Sasol in their production of synthetic renewable fuels.

“The methane can also be separated from the carbon dioxide and compressed into bottles, creating compressed biomethane. This can be used as a replacement for liquid petroleum gas (LPG), as well as petrol and diesel in vehicles, such as bakkies, tractors, buses, and delivery trucks.”

The carbon dioxide produced in the process can, for example, be used to replace the fossil-based carbon dioxide typically used in the production of carbonated beverages. Additionally, it can be applied to extend the shelf life of packaged foods, serve as a water softener, and even be applied to a variety of industrial applications.

Commercialisation 

Biogas/biomethane is already produced in Mexico on a commercial scale. In Northeast Brazil, farmers have planted 600 000 hectares of spineless cactus, also known as Palma Forrageira, but the machinery needed to harvest it only became commercially available this year.

Back home in South Africa, just 30 km outside of Bloemfontein, Barren Energy farm is at Stage 1 with 140 hectares of high-density cactus planted to provide the initial feedstock for anaerobic digestion. With 600 hectares, they will be able to produce five million litres of diesel-equivalent methane.

Tarrisse says, “With the right methodology and management system, producing biogas from the spineless cactus will be adopted relatively quickly on a commercial scale.”

He believes that the lack of investment in cultivating the spineless cactus as a crop for fodder in South Africa may be due to a few factors. “It is easier to stick to what is known, such as irrigating lucerne and maize and managing these crops with existing planters, pest management solutions, and harvesting machinery than to develop local machinery and management solutions for a perfectly adapted crop,” he says. 

Compelling reasons

According to Tarrisse, there are several compelling reasons to consider the spineless cactus as a source of biogas in South Africa.

Firstly, he explains, “Only the cactus pads, harvested from high-density plantations (20 000 plants per hectares), are used for biogas production.”

“Secondly, the spineless cactus can yield large volumes of biomass from marginal semi-arid land where conditions are unsuitable for conventional crop cultivation. This makes it an ideal option for the 65% of South African land that receives less than 500 mm of rainfall annually.”

Thirdly, he says, “The plant contains 30 to 50% of easily digestible sugars, which degrades easily in an anaerobic digester. This simple, low-tech process can provide a substantial amount of baseload energy with relatively limited capital expenditure, which is particularly important in developing countries such as South Africa where capital is difficult to raise.”

“On top of that, anaerobic digestion only extracts carbon, oxygen, and hydrogen molecules from the cactus, while most of the macro- and micronutrients, water, and some fibres remain in the digestate. This nutrient-rich cactus digestate can then be spread on the cactus fields, reducing the need for fertiliser once the plantation has been fertilised in the first two years of implementation.”

Societal impact

Besides the benefits of producing biogas from the cactus plant, there is also the opportunity of job creation. “This farming can create one million direct job opportunities from only 3% of South Africa’s land area, approximately 4 million hectares,” says Tarrisse.

He is of the opinion that if production was at scale, as opposed to the current small orchard-style farming of cactus, there would be substantial biomass available to sustain not only biomethane, but also to support various bio-industries, such as protein production through cactus fermentation, biomaterials as a substitute for wood-based cellulose, organic acids, and bioplastics. “Consequently, cactus provides a climate-resilient, drought-resistant, and perennial feedstock for food, feed, fibre, and fuel in semi-arid Southern Africa,” he says.

Tarrisse states that this initiative also has the potential to significantly reduce migration from rural to urban areas, therefore addressing issues related to the growth of urbanisation, such as the provision of infrastructure and crime.

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept